Varenicline for the Treatment of Smokeless Tobacco

NACompletedINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

October 31, 2010

Study Completion Date

January 31, 2011

Conditions
Nicotine Dependence
Interventions
DRUG

varenicline

12 weeks of varenicline 1 mg by mouth twice per day

DRUG

placebo

12 weeks of placebo (double blinded) by mouth twice per day

Trial Locations (1)

55905

Nicotine Research Program, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

Mayo Clinic

OTHER